ロード中...
Platelet-Derived Growth Factor as an Antidepressant Treatment Selection Biomarker: Higher Levels Selectively Predict Better Outcomes with Bupropion-SSRI Combination
BACKGROUND: Platelet derived growth factor is integral to maintenance of blood brain barrier, increases in response to blood brain barrier disruption, and may reflect neuroinflammation. Based on previous reports of better outcomes with dopaminergic antidepressants in depressed patients with elevated...
保存先:
| 出版年: | Int J Neuropsychopharmacol |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Oxford University Press
2017
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5737519/ https://ncbi.nlm.nih.gov/pubmed/29016822 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ijnp/pyx060 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|